FIELD: medicine.
SUBSTANCE: pentoxifylline is intravenously administered in a daily dose of 5 mg/kg of newborn's body weight for the first three days of life.
EFFECT: method enables providing the considerably higher clinical effectiveness, causes no severe complications; it is accessible and efficient.
1 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING SEVERITY LEVEL OF FULL-TERM NEWBORN'S STATE ACCORDING TO ACID AND OSMOTIC ERYTHROGRAMS | 2009 |
|
RU2396564C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF VENTRICULOMAGALY IN NEONATALS AFTER PERINATAL HYPOXIA | 2006 |
|
RU2314526C1 |
| METHOD FOR RESTORING AND KEEPING FAMILY HEALTH | 2002 |
|
RU2230558C2 |
| METHOD FOR PREDICTING INTRAVENTRICULAR HEMORRHAGES IN MATURE NEWBORNS | 2000 |
|
RU2187964C2 |
| METHOD OF CEREBRAL ISCHEMIA CONSEQUENCE DEVELOPMENT FORECAST FOR INFANTS | 2008 |
|
RU2392859C1 |
| METHOD FOR CARRYING OUT BIOCHEMICAL CARDIAC ACTIVITY ESTIMATION IN NEWBORN BABIES | 2004 |
|
RU2274867C2 |
| METHOD FOR DETERMINING DEGREE OF SEVERITY OF INFANTILE CEREBRAL PARALYSIS IN INFANTS | 2013 |
|
RU2554752C2 |
| DIAGNOSTIC TECHNIQUE FOR DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORNS OF PERINATAL RISK GROUP | 2013 |
|
RU2530666C1 |
| METHOD FOR PREDICTING CEREBRAL DISORDERS IN NEONATALS IN MOTHERS FROM HIGH-RISK GROUP | 2005 |
|
RU2290644C1 |
| METHOD FOR PREDICTION OF DEVELOPING MULTIPLE ORGAN FAILURE IN NEWBORNS IN CRITICAL STATE | 2015 |
|
RU2585143C1 |
